China Prescription Drug 2008 Issue 1 zi xun xin xi

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

China Prescription Drug
1671-945X
2008 Issue 1

zi xun xin xi

..............page:3,6,10-13

xin de sheng yin , ti xian quan mian ke guan

..............page:5

yao qi ying zhong shi yao pin feng xian ping gu

..............page:5

neng rong hua man tian bing xue de dong xi

..............page:2

yu ling fu nv he bing shen jing mai xue shuan shuan sai ji fei shuan sai 24 li bao gao ji wen xian fu xi
liu shuang ; xu xiao feng ; liu ze ying ; zong hua ; gao wei ; yang jing hua

..............page:74-75

Glimpse of Blood Regulating Agents in Hospital Pharmacy Market:White-hot Competition of Multiple Competitive Brands
zong yun gang

..............page:76-77

lin chuang yi sheng ying ru he xue xi bing ying yong zhi nan

..............page:79

Harmony Regained

..............page:44-45

Close Relationship between Physicians and Patients——Evolution from Information Technology

..............page:42-43

heng liang yi yuan yao xue fu wu zhi liang de biao chi di si jie zhong guo yao shi lun tan guan zhu " xin shi qi de yao pin xin xi he yao xue fu wu "

..............page:14-19

2007:Spotlight on drug safety

..............page:8-9

Will There Ever Be an AIDS Vaccine?

..............page:7

On Implicit Risk of Drug-Analysis of Origin of the Risk of Risk Management of Drags
wu zhi ang ; bi kai shun

..............page:49-51

Cause and Effect of Risk Assessment-On Relaunching of Aloselron after Withdrawal

..............page:46-49

Fast Progress of Drug Treamaent for Breast Cancer

..............page:69-72

Renew of Lung Cancer Study in 2007
lu shun ; ai xing zuo

..............page:64-68

R&D of New Lipid Lowering Agents(LLA):Status Quo and Prospect
ye ping ; wang fan

..............page:61-63

Therapy for Hypertension:New Evidence-based Views
wei yu zuo ; liao yu hua

..............page:58-61

Do Hypotensive Agents Protect Cardiovascular System?
tang bo zuo ; yan xiao wei

..............page:56-57

Evidence Based Medicine and Clinical Practice in Cardiovascular Diseases
chen zuo zhu ; jin xue juan

..............page:52-55

Proceeding to Good Adminstration——Perspectives from Reforms of SFDA in 2007

..............page:20-23

Profile:Dr.Fu He-liang,CEO of Techpool Bio-Pharma Co.,Ltd.

..............page:40-41

Sunshine Pursuing,Life Respecting

..............page:38-39

Critical Situation for Clinical Promotion of Pharmaceuticai Companies in the Transformation Period-Lose on the Swings and Get back on the Roundabouts

..............page:34-37

Innovation,Three ParalleI Roadmaps

..............page:31-33

Innovative Pharmaceutical Company after Raising Stmtegic Capital

..............page:28-30

Struggling for Accessing to the Road to Success——Analvsis of the Growth of Chinese Pharmas

..............page:24-27